98 related articles for article (PubMed ID: 7543953)
41. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
Dubois C; Schlageter MH; de Gentile A; Guidez F; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y
Blood; 1994 Jun; 83(11):3264-70. PubMed ID: 8193361
[TBL] [Abstract][Full Text] [Related]
42. In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells.
Hsu HC; Tsai WH; Chen PG; Hsu ML; Ho CK; Wang SY
Eur J Haematol; 1999 Jul; 63(1):11-8. PubMed ID: 10414449
[TBL] [Abstract][Full Text] [Related]
43. Tyrosine kinases but not cAMP-dependent protein kinase mediate the induction of leukocyte alkaline phosphatase by granulocyte-colony-stimulating factor and retinoic acid in acute promyelocytic leukemia cells.
Gianni M; Li Calzi M; Terao M; Rambaldi A; Garattini E
Biochem Biophys Res Commun; 1995 Mar; 208(2):846-54. PubMed ID: 7535055
[TBL] [Abstract][Full Text] [Related]
44. The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia.
Miyauchi J; Inatomi Y; Ohyashiki K; Asada M; Mizutani S; Toyama K
Leuk Res; 1997 Apr; 21(4):285-94. PubMed ID: 9150345
[TBL] [Abstract][Full Text] [Related]
45. Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.
Uchino Y; Iriyama N; Hatta Y; Takei M
Cancer Cell Int; 2015; 15():30. PubMed ID: 25805962
[TBL] [Abstract][Full Text] [Related]
46. Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.
Hofmann WK; Ganser A; Seipelt G; Ottmann OG; Zander C; Geissler G; Hoffmann K; Höffken K; Fischer JT; Isele G; Hoelzer D
Ann Hematol; 1999 Mar; 78(3):125-30. PubMed ID: 10211754
[TBL] [Abstract][Full Text] [Related]
47. Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia.
Itoh S; Sugawara T; Enomoto S; Ono Y; Numaoka H; Utsugisawa T; Murai K; Ishida Y; Kuriya S
Am J Hematol; 2002 Jan; 69(1):59-63. PubMed ID: 11835333
[TBL] [Abstract][Full Text] [Related]
48. [Research Advances on Mechanisms of Resistance to All-Trans Retinoic Acid in Acute Promyelocytic Leukemia--Review].
Niu YN; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):2024-2029. PubMed ID: 31839078
[TBL] [Abstract][Full Text] [Related]
49. Granulocyte colony-stimulating factor and its receptor in acute promyelocytic leukemia.
Katayama N; Kita K; Kawakami K; Mitani H; Sugawara T; Mizuno S; Yonezawa A; Nishii K; Miwa H; Wada H; Minami N; Shiku H
Am J Hematol; 1998 May; 58(1):31-5. PubMed ID: 9590146
[TBL] [Abstract][Full Text] [Related]
50. Granulocyte colony-stimulating factor-induced terminal maturation of human myeloid cells is specifically associated with up-regulation of receptor-mediated function and CD10 expression.
Inazawa Y; Saeki K; Yuo A
Int J Hematol; 2003 Feb; 77(2):142-51. PubMed ID: 12627849
[TBL] [Abstract][Full Text] [Related]
51. Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia.
Charles KS; Kanaa M; Winfield DA; Reilly JT
Clin Lab Haematol; 2000 Jun; 22(3):171-4. PubMed ID: 10931168
[TBL] [Abstract][Full Text] [Related]
52. Combination therapy with granulocyte colony-stimulating factor, all-trans retinoic acid, and low-dose cytotoxic drugs for acute myelogenous leukemia.
Usuki K; Kitazume K; Endo M; Ito K; Iki S; Urabe A
Intern Med; 1995 Dec; 34(12):1186-9. PubMed ID: 8929647
[TBL] [Abstract][Full Text] [Related]
53. Acute promyelocytic leukaemia, tretinoin, and granulocyte colony-stimulating factor.
Nakajima K; Hatake K; Miyata T; Muroi K; Komatsu N; Miura Y
Lancet; 1994 Jan; 343(8890):173-4. PubMed ID: 7506343
[No Abstract] [Full Text] [Related]
54. Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy.
Lazzarino M; Corso A; Regazzi MB; Iacona I; Bernasconi C
Br J Haematol; 1995 Aug; 90(4):928-30. PubMed ID: 7669674
[TBL] [Abstract][Full Text] [Related]
55. Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF).
Vaickus L; Villalona-Calero MA; Caligiuri T
Leukemia; 1993 Oct; 7(10):1680-1. PubMed ID: 7692195
[No Abstract] [Full Text] [Related]
56. Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.
Usuki K; Endo M; Osawa M; Kitazume K; Iki S; Urabe A
Int J Hematol; 1996 Jan; 63(1):19-23. PubMed ID: 8713573
[TBL] [Abstract][Full Text] [Related]
57. All-trans retinoic acid-induced, life-threatening complete atrioventricular block.
Shih CH; Wu HB
J Chin Med Assoc; 2015 May; 78(5):316-9. PubMed ID: 25726499
[TBL] [Abstract][Full Text] [Related]
58. Acute Promyelocytic Leukemia in Late Pregnancy. Successful Treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy.
Delgado-Lamas JL; GarcéS-Ruiz OM
Hematology; 1999; 4(5):415-8. PubMed ID: 27426845
[TBL] [Abstract][Full Text] [Related]
59. A rare case of perimyocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia.
Ben El Makki A; Mahtat EM; Kheyi J; Bouzelmat H; Chaib A
Med Pharm Rep; 2019 Oct; 92(4):418-420. PubMed ID: 31750445
[TBL] [Abstract][Full Text] [Related]
60. [Acute renal failure in patient treated with ATRA and amphotericin B: case report].
Moresco G; Martinello F; Souza LC
J Bras Nefrol; 2011; 33(2):276-81. PubMed ID: 21789447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]